Position in RLAY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$58,516,720
+$29,258,389 QoQ
Shares Held
3,127,564
+6.4% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 256 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 90%
Shared 6%
None 4%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. RLAY ranks #27 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in RLAY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,516,720 | 3,127,564 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $29,258,331 | 2,940,536 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $20,983,759 | 2,480,350 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,960,996 | 2,482,950 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,651,529 | 2,789,460 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,333,616 | 2,799,091 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $12,215,786 | 2,964,997 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,380,533 | 1,748,663 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $9,912,614 | 1,520,340 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $13,286,753 | 1,600,814 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $14,964,293 | 1,359,155 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $8,558,585 | 1,017,668 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $14,624,687 | 1,164,386 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $20,353,541 | 1,235,795 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,814,631 | 1,058,543 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $14,218,527 | 635,607 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,595,999 | 393,791 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,731,929 | 57,866 | Shares | Defined | 2022-05-13 | |
| 2021-06-30 | $228,175 | 6,236 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $215,578 | 6,236 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||